FDA toughens up on medical devices

The FDA asked several medical-device makers to justify the safety and effectiveness of products already on the market, as part of a move to require tougher evidence standards before products can be sold. The requests for data affect Johnson & Johnson, Medtronic and Abiomed, among others. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.